|By Marketwired .||
|March 31, 2014 09:15 AM EDT||
LOS ANGELES, CA -- (Marketwired) -- 03/31/14 -- Decision Diagnostics Corp. (OTCBB: DECN), the exclusive worldwide sales, service and regulatory processes agent for the Shasta GenStrip, the Green Glucose Test Strip, specifically designed to work with the Johnson & Johnson's (NYSE: JNJ) LifeScan Ultra family of glucose testing meters, today announced that its Pharma Tech Solutions subsidiary has completed and will air in many regions in the U.S. its new commercial video titled "GenStrip: Monolith." The video is available for viewing at:
The company will publish a media schedule for GenStrip: "Monolith" just as soon as all previously purchased commercial spots for the GenStrip "A Patchwork of Life" spots are completed. The new GenStrip commercial will be played in most metropolitan areas beginning April 5, 2014. Time has also been booked from a nationwide service for the local hours of 1:00 pm through 6:00 pm. However, the bulk of the 12,500 purchased commercial plays for thirty days beginning April 5, 2014 will be via saturated cable television buys during late at night hours, a time tested method used for diabetes and over-the-counter pharmaceutical products.
DECN is also a leading provider of prescription and non-prescription diagnostics, home testing products for the chronically ill and a premier developer of revolutionary cell phone centric e-health products and technologies. DECN's GenStrip product was cleared by the U.S. FDA in November 2012, and after several successful long running legal battles with a division of Johnson & Johnson, Genstrip was finally introduced to the market in late 2013 as a lower cost (60%) alternative for user/owners of Johnson and Johnson LifeScan OneTouch® Ultra®, Ultra2® and Ultra Mini® glucose meters.
This release contains forward-looking statements about our business or financial condition that reflect our assumptions and beliefs based on information currently available. We can give no assurance that the expectations indicated by such forward-looking statements will be realized. There may be other risks and circumstances that we are unable to predict. When used in this release, words such as "believes," "expects," "forecasts," "intends," "projects," "plans," "anticipates," "estimates," "will" and similar expressions are intended to identify forward-looking statements, although there may be certain statements not accompanied by such expressions.
GenStrip test strips are a product of Pharma Tech Solutions, Inc. and are not manufactured, distributed, endorsed, or approved by, nor associated with, LifeScan®, Inc. a Johnson & Johnson® Company, manufacturers and distributors of the OneTouch® Ultra® Family of meters and OneTouch® Ultra® test strips.
Decision Diagnostics Corp.
Oct. 20, 2016 05:30 PM EDT Reads: 2,763
Oct. 20, 2016 05:30 PM EDT Reads: 828
Oct. 20, 2016 05:15 PM EDT Reads: 3,555
Oct. 20, 2016 05:15 PM EDT Reads: 10,958
Oct. 20, 2016 03:45 PM EDT Reads: 877
Oct. 20, 2016 03:45 PM EDT Reads: 2,654
Oct. 20, 2016 03:00 PM EDT Reads: 3,749
Oct. 20, 2016 03:00 PM EDT Reads: 5,861
Oct. 20, 2016 02:15 PM EDT Reads: 836
Oct. 20, 2016 02:15 PM EDT Reads: 2,634
Oct. 20, 2016 02:15 PM EDT Reads: 9,556
Oct. 20, 2016 01:45 PM EDT Reads: 7,846
Oct. 20, 2016 01:45 PM EDT Reads: 2,128
In his keynote at 18th Cloud Expo, Andrew Keys, Co-Founder of ConsenSys Enterprise, provided an overview of the evolution of the Internet and the Database and the future of their combination – the Blockchain. Andrew Keys is Co-Founder of ConsenSys Enterprise. He comes to ConsenSys Enterprise with capital markets, technology and entrepreneurial experience. Previously, he worked for UBS investment bank in equities analysis. Later, he was responsible for the creation and distribution of life sett...
Oct. 20, 2016 01:30 PM EDT Reads: 5,054
Oct. 20, 2016 01:30 PM EDT Reads: 711